Insider holders · CIK 0001326205
IGC Pharma, Inc. · IGC
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Ram MukundaExec. Chairman & CEO | 6,875,563 | 492,417 | 7,367,980 | Jul 1, 2026 · 9:01 am EDT | Form 4 |
| Claudia GrimaldiPFO | 3,421,092 | — | 3,421,092 | Jul 1, 2026 · 9:00 am EDT | Form 4 |
| Sudhakar V ShenoyDirector | 1,045,000 | — | 1,045,000 | Aug 29, 2018 · 6:48 pm EDT | Form 4 |
| John CherinCFO, Treasurer and PAO | 325,000 | — | 325,000 | Sep 14, 2017 · 3:11 pm EDT | Form 4 |
| Richard K PrinsDirector | 268,000 | — | 268,000 | May 10, 2018 · 8:47 pm EDT | Form 5 |
| Rohit GoelManager & PAO | 100,000 | — | 100,000 | Jul 12, 2018 · 11:27 am EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.